Motoki Yoshida

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

Yasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto et al. · The Lancet Oncology · 2013 · 253 citations

Medicine, Oncology, Pharmacology +12

A new technique for endoscopic mucosal resection with an insulated-tip electrosurgical knife improves the completeness of resection of intramucosal gastric neoplasms

Shin’ichi Miyamoto, Manabu Muto, Yasuo Hamamoto et al. · Gastrointestinal Endoscopy · 2002 · 229 citations

Medicine, Oncology, Surgery +14

Randomized Phase II Trial Comparing Nitroglycerin Plus Vinorelbine and Cisplatin With Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non–Small-Cell Lung Cancer

Hiroyasu Yasuda, Mutsuo Yamaya, Katsutoshi Nakayama et al. · Journal of Clinical Oncology · 2006 · 168 citations · Full text

Medicine, Oncology, Pharmacology +10

Nitroglycerin Treatment May Enhance Chemosensitivity to Docetaxel and Carboplatin in Patients with Lung Adenocarcinoma

Hiroyasu Yasuda, Katsutoshi Nakayama, Mika Watanabe et al. · Clinical Cancer Research · 2006 · 117 citations

Medicine, Oncology, Pharmacology +13

A Randomized, Single‐Blind Study of Lansoprazole for the Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease in Older Patients

T. Sasaki, Katsutoshi Nakayama, Hiroyasu Yasuda et al. · Journal of the American Geriatrics Society · 2009 · 98 citations

Medicine, Internal Medicine, Pharmacotherapy +16